ADMA Earnings

Quarterly EPS
$0.15
Q3 2024
$0.47
Q4 2024
$0.11
Q1 2025
$0.14
Q2 2025
$0.15
Q3 2025
$0.21
Q4 2025
$0.19
Q1 2026
$0.17
Q2 2026
Latest Revenue124.4M
Latest Net Income37.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.17124.4M37.8M+2.0%+21.4%
Q1 2026$0.19114.5M45.3M-0.3%+72.7%
Q4 2025$0.21139.2M49.4M+18.4%-55.3%
Q3 2025$0.15134.2M36.4M+12.0%+0.0%
Q2 2025$0.14122.0M34.2M+13.8%+0.0%
Q1 2025$0.11114.8M26.9M+40.2%+37.5%
Q4 2024$0.47117.5M111.9M+59.1%+687.5%
Q3 2024$0.15119.8M35.9M+78.1%+1,400.0%
Q2 2024$0.14107.2M32.1M
Q1 2024$0.0881.9M17.8M
Q4 2023-$0.0873.9M-17645000
Q3 2023$0.0167.3M2.6M
ADMA Biologics (ADMA) — Earnings